| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000016682 |
| Receipt No. | R000019358 |
| Official scientific title of the study | Multicenter Japanese anaphylaxis registry |
| Date of disclosure of the study information | 2015/03/02 |
| Last modified on | 2017/03/03 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Multicenter Japanese anaphylaxis registry | |
| Title of the study (Brief title) | Multicenter Japanese anaphylaxis registry | |
| Region |
|
|
| Condition | |||||||
| Condition | Anaphylaxis | ||||||
| Classification by specialty |
|
||||||
| Classification by malignancy | Others | ||||||
| Genomic information | NO | ||||||
| Objectives | |
| Narrative objectives1 | The purpose of this study is to clarify the causes and clinical course of anaphylaxis in Japan. |
| Basic objectives2 | Others |
| Basic objectives -Others | observational study
|
| Trial characteristics_1 | Others |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The purpose of this study is to clarify causes of anaphylaxis in Japan. |
| Key secondary outcomes | To evaluate as follows;
1)Severity of anaphylaxis 2)Outcome of anaphylaxis 3)Difference of cause by region and season 4) Rate of adrenaline self-injection use 5)Prescription of adrenaline self-injection when going home, and education contents |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The anaphylaxis subjects who visited at the recognized training facilities of Japanese Society of Allergology.
Definition of anaphylaxis is based on World Allergy Organization guidelines for the assessment and management of anaphylaxis. |
|||
| Key exclusion criteria | None | |||
| Target sample size | 1000 | |||
| Research contact person | |
| Name of lead principal investigator | Motohiro Ebisawa |
| Organization | National Hospital Organization Sagamihara National Hospital |
| Division name | Department of Allergy, Clinical Research Center for Allergy and Rheumatology |
| Address | 18-1, sakuradai, minamiku, sagamiharashi, kanagawa, Japan, 252-0392. |
| TEL | 042-742-8311 |
| foodallergy@sagamihara-hosp.gr.jp | |
| Public contact | |
| Name of contact person | Sakura Sato |
| Organization | National Hospital Organization Sagamihara National Hospital |
| Division name | Department of Allergy, Clinical Research Center for Allergy and Rheumatology |
| Address | 18-1, sakuradai, minamiku, sagamiharashi, kanagawa, Japan, 252-0392. |
| TEL | 042-742-8311 |
| Homepage URL | |
| s-satou@sagamihara-hosp.gr.jp | |
| Sponsor | |
| Institute | National Hospital Organization Sagamihara National Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Pfizer |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | The recognized training facilities of Japanese Society of Allergology |
| Name of secondary funder(s) | None |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 国立病院機構 相模原病院 小児科(神奈川県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | To analyze the relationship between causes, triggers, patients characteristics and clinical course of anaphylaxis |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000019358 |